Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
Articles
[키워드] addition
adverse event
angina
appear
authorisation
calibrated
case sery
chest pain
cohort study
Combination
Cox model
Denmark
Department
determine
development
electronic medical record
Emergency use
estimate
European
Federation
finding
foundation
funding
Germany
hazard ratio
heart failure
Horizon
HRs
Hydroxychloroquine
hydroxychloroquine plus azithromycin
hydroxychloroquine treatment
increase
increased risk
initiative
Innovation
IQVIA
janssen
Japan
less
Medical Research Council
Medicine
Ministry of Health
Mortality
negative control
Netherlands
NIHR
Older
outcome
Oxford
partnership
Patient
patients with COVID-19
pharmaceutical
Pneumonia
populations
Propensity score
Research
Retrospective study
rheumatoid arthritis
risk
routine care
severe adverse event
Singapore
Spain
Stratification
sulfasalazine
training
treat
Treatment
USA
use of hydroxychloroquine
veteran
Welfare
were used
[DOI] 10.1016/S2665-9913(20)30276-9 PMC 바로가기 [Article Type] Articles
[DOI] 10.1016/S2665-9913(20)30276-9 PMC 바로가기 [Article Type] Articles